| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/1997 | CN1148392A Peptide derivative |
| 04/23/1997 | CN1148391A Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamido-naphthalene derivatives |
| 04/23/1997 | CN1148343A Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 04/23/1997 | CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn. |
| 04/23/1997 | CN1147939A Medicine for curing diabetes extracted from initial milk of cow |
| 04/23/1997 | CN1034672C Alpha or beta chains dimeric compound of inhibitor for human being or pigs, and method for producing same |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/23/1997 | CN1034630C Prepn. of composition including binding |
| 04/22/1997 | US5623065 Gapped 2' modified oligonucleotides |
| 04/22/1997 | US5623057 Pneumococcal polysaccharide conjugate vaccine |
| 04/22/1997 | US5623056 Immunomodulators |
| 04/22/1997 | US5623052 Oligopeptide |
| 04/22/1997 | US5623050 Stable polypeptides having c-AMP production enhancing activity and the use thereof |
| 04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
| 04/22/1997 | US5622985 Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
| 04/22/1997 | US5622983 N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives |
| 04/22/1997 | US5622973 Bone disorders |
| 04/22/1997 | US5622959 Method of treating retroviral infections in mammals |
| 04/22/1997 | US5622949 Aids therapy |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622935 Medicine for preventing and curing bone fracture |
| 04/22/1997 | US5622934 Treating diabetes mellitus |
| 04/22/1997 | US5622933 Multiple branch peptide constructions for use against HIV |
| 04/22/1997 | US5622932 IGF-1 superagonists |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622930 C1 inhibitor muteins and uses thereof |
| 04/22/1997 | US5622928 Glia activation factor and its production |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622862 A cell line encoding tyrosine kinase receptor protein treating neurological disorders |
| 04/22/1997 | US5622861 Recombinant DNA encoding hepatitis A virus receptor |
| 04/22/1997 | US5622860 Genes encoding melanocortin receptors |
| 04/22/1997 | US5622854 Method and reagent for inhibiting T-cell leukemia virus replication |
| 04/22/1997 | US5622852 Polynucleotide comprising sequence encoding mammalian bcl-xl/bcl-2 associated death promoter polypeptide |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/22/1997 | US5622843 Phospholipid transfer proteins and DNA encoding them |
| 04/22/1997 | US5622842 DNA encoding canine immunoglobulin A |
| 04/22/1997 | US5622839 Recombinant production of human calcitonin receptor polypeptides |
| 04/22/1997 | US5622836 Monoclonal antibodies which recognize malignant cells from bladder carcinomas |
| 04/22/1997 | US5622832 Arachidonic acid releasing phospholipase A2 enzyme and methods of use |
| 04/22/1997 | US5622828 Contacting mixture of nucleic acids with secretory phospholipase a2, partitioning increased affinity nucleic acids, amplifying |
| 04/22/1997 | US5622714 Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and process for its production |
| 04/22/1997 | US5622706 Synthetic polypeptide comprising amino acid sequence of mature stx gene; accellular vaccines |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | US5622700 Administering initial dosage of antibody, subsequent intermittent dosing |
| 04/22/1997 | US5622690 Seed-derived proteinaceous compositions for reduction of sunburn cell formation |
| 04/17/1997 | WO1997014038A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | WO1997013867A1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences |
| 04/17/1997 | WO1997013866A2 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/17/1997 | WO1997013861A1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/17/1997 | WO1997013860A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | WO1997013859A1 A novel haematopoietic cytokine and uses therefor |
| 04/17/1997 | WO1997013858A2 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 04/17/1997 | WO1997013857A1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 04/17/1997 | WO1997013856A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | WO1997013855A1 Melanoma-associated protein |
| 04/17/1997 | WO1997013854A1 Pilosulin 2 |
| 04/17/1997 | WO1997013852A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | WO1997013846A1 Tyrosine kinase gene and gene product |
| 04/17/1997 | WO1997013845A2 Phosphopantetheinyl transferases and uses thereof |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013787A1 Vegf-binding polypeptide |
| 04/17/1997 | WO1997013786A1 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 04/17/1997 | WO1997013783A1 An acceptor polypeptide for an n-acetylgalactosaminyltransferase |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013778A1 A metastasis suppressor gene |
| 04/17/1997 | WO1997013530A1 USE OF A VECTOR CAUSING Bcl-2 EXPRESSION OR A TEMPORARY INCREASE IN Bcl-2 ACTIVITY |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013527A1 Treatments of helicobacter pylori infections |
| 04/17/1997 | WO1997013526A1 Method of improving lipid digestion |
| 04/17/1997 | WO1997013525A1 Use of il-4 to treat psoriasis |
| 04/17/1997 | WO1997013524A1 Use of a polypeptide having soluble human cd16 activity for treating hiv infection |
| 04/17/1997 | WO1997013522A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | WO1997013520A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | WO1997013507A1 Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 04/17/1997 | WO1997013502A2 Prolonged release of gm-csf |
| 04/17/1997 | WO1997013500A2 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 04/17/1997 | WO1997013493A1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
| 04/17/1997 | WO1997013489A2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 04/17/1997 | WO1997013410A1 Hybrid molecules containing amidated polypeptide binding ligands |
| 04/17/1997 | WO1997008318A3 Compounds and methods for treatment and diagnosis of prostate cancer |
| 04/17/1997 | WO1997005870A3 Use of griseofulvin for inhibiting the growth of cancers |
| 04/17/1997 | WO1997005251A3 Feline stem cell factor |
| 04/17/1997 | WO1996030523A3 Antigen presentation system based on retrovirus-like particles |
| 04/17/1997 | WO1996028468A3 Amphiphilic peptide and analogs thereof |
| 04/17/1997 | WO1996017072A3 Recombinant alphavirus vectors |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2491511A1 Prolonged release of gm-csf |
| 04/17/1997 | CA2234723A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2234158A1 Treatments of helicobacter pylori infections |
| 04/17/1997 | CA2233313A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | CA2232813A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | CA2232231A1 Pilosulin 2 |
| 04/17/1997 | CA2232155A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | CA2231647A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | CA2208215A1 Liposome formulations of 5.beta. steroids |
| 04/17/1997 | CA2207302A1 Neisseria meningitidis subunit tbp2 |
| 04/16/1997 | EP0768380A2 Gene regulating aureobasidin sensitivity |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |
| 04/16/1997 | EP0768378A1 Dna coding for caldecrin and process for producing caldecrin by using the dna |